Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine
Annals of Internal Medicine · 2025
DOI: 10.7326/annals-24-02409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine, 2025. Verfasst von Nadja A Vielot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (N.A.V.). Hauptthemen laut MEDLINE: Herpes Zoster Vaccine, Herpes Zoster, Immunocompetence, Vaccine Efficacy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (N.A.V.).
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (M.J.F., T.S., J.L.L.).
- Global Vaccine Safety, Novavax, Gaithersburg, Maryland (J.F.).
- Department of Family Medicine, School of Medicine, and Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (S.B.).
- Department of Epidemiology, Gillings School of Global Public Health, and Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (D.J.W.).
ORCID-Profile: Nadja A Vielot, Michele Jonsson Funk, Til Stürmer, Sylvia Becker-Dreps, Jennifer L Lund
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
Zitieren
APA
Vielot, N. A., Jonsson Funk, M., Stürmer, T., Fix, J., Becker-Dreps, S., Weber, D. J., & Lund, J. L. (2025). Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine. Annals of Internal Medicine. https://doi.org/10.7326/annals-24-02409
Vancouver
Vielot NA, Jonsson Funk M, Stürmer T, Fix J, Becker-Dreps S, Weber DJ, et al. Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine. Annals of Internal Medicine. 2025. doi:10.7326/annals-24-02409
BibTeX
@article{Vielot2025,
author = {Vielot, Nadja A and Jonsson Funk, Michele and Stürmer, Til and Fix, Jonathan and Becker-Dreps, Sylvia and Weber, David J and Lund, Jennifer L},
title = {Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine},
journal = {Annals of Internal Medicine},
year = {2025},
doi = {10.7326/annals-24-02409}
}
EUVIMED